Macroaxis: Personalized Investing
Simple Personalized Investing

S&P 500   1,668   0.40  Index Moved Up 0.02%
PRGO HLF PBH USNA Market Drivers Railroads Airlines Technology 
United States  USA  |  Screen Global Equities


Processing
Collecting data for AUXL

Auxilium quote and profile

 
 Companies |  Insiders  | Dashboard  
     
15.0
  
STOCK
(0.01)  Macroaxis: -0.07 Down   0.07%  
Year To Date
15.6929.37
Trading Day 
14.9415.16
May 20 2013 

Diversification Suggestion

Use Auxilium to protect against small markets fluctuations. The stock experiences normal downward trend and little activity
Analyze Auxilium Pharmaceuticals Trend or Check current 30 days Auxilium correlation with market (S&P 500)
1 Month Beta 0.39  
Highest Price:  
Lowest Price:  
16.53  
14.0  
April 22 2013 
April 29 2013 
As returns on market increase, Auxilium returns are expected to increase less than the market. However during bear market, the loss on holding Auxilium will be expected to be smaller as well.
Auxilium Pharmaceuticals Inc Small BetaAuxilium Pharmaceuticals Beta Legend
AUXL United States Nasdaq
Auxilium Pharmaceuticals Inc
Healthcare
Drug Related Products
http://www.auxilium.com
Contact Number: 484. 321. 5900
Currency: USD - US Dollar
Traded on NASDAQ
    
Current Valuation631.79 M
Shares Outstanding49.23 M
Number of Shares Shorted4.94 M
Revenue395.28 M
 United States Nasdaq   0.97 % Macroaxis: 0.97 Moved Up  
 
 United States NYSE   0.12 % Macroaxis: 0.12 Moved Up  
 
 United States Russel   0.06 % Macroaxis: 0.06 Moved Up  
 
 United States SP 500   0.02 % Macroaxis: 0.02 Moved Up  
 
 thisRed AUXL AUXL agains markets  0.07 % Macroaxis: 0.07 Moved Down  
 
Compare to Competition Get Alpha   Get Advice

Auxilium Leadership

Adrian Adams CEO and President and Director
Rolf Classon Independent Chairman of the Board
Mark Glickman Senior Vice President - Sales, MBA
Richard Dudek Senior Vice President - Marketing

Auxilium Price and Market Media

The median price of Auxilium for the period between Sat, Apr 20, 2013 and Mon, May 20, 2013 is 15.16 with a coefficient of variation of 4.27. The daily time series for the period is distributed with a sample standard deviation of 0.65, arithmetic mean of 15.25, and mean deviation of 0.49. The Stock received some media coverage during the period.
Auxilium         Market
Price Growth (%)
 
1
Auxilium Pharmaceuticals Inc. Cytokinetics Incorporated ...04/30/2013Macroaxis: News
2
Treatment for Painful Curved Penis Shows Promise05/09/2013Macroaxis: News
3
Auxilium Pharma To Present At Bank Of America ConferenceWebc...05/16/2013Macroaxis: News

Auxilium Summary

Auxilium Pharmaceuticals Inc [AUXL] is traded on NASDAQ in USA. It is located in Malvern, PA and employs 526 people. The company currently falls under 'Small-Cap' category with current market capitalization of 689.26 M. Auxilium Pharmaceuticals Inc conducts business under Healthcare sector and is part of Drug Related Products industry. This company has 49.23 M outstanding shares of which 4.94 M shares are presently shorted by private and institutional investors with about 9.2 trading days to cover.
Auxilium Pharmaceuticals, Inc., a specialty biopharmaceutical company, together with its subsidiaries, develops and markets pharmaceutical solutions worldwide. more
Past Market
Over 30
Days
0
Out Of
100
 
Chance of
Less
Than
45 %
 
Follow Auxilium with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker
Add To Reader
 
Add Auxilium to your reader
 

Auxilium Research Report

Auxilium vs. Perrigo

Correlation analysis and fundamentals comparison between Auxilium Pharmaceuticals and Perrigo Co

Auxilium Executives

James Fickenscher CFO and Principal Accounting Officer

Auxilium Directors

Paul Friedman Independent Director
Nancy Lurker Independent Director, MBA
Alfred Altomari Independent Director, MBA
William McKee Independent Director
Peter Brandt Independent Director, MBA

Auxilium Management

Karen Cashmere Sr. VP of New Product Marketing
Elizabeth Jobes Chief Compliance Officer

Auxilium Fundamentals

Current Liabilities vs Number of Shares Shorted
Revenue vs Net Income
Current Liabilities vs Number of Employees
One Year High vs Net Income

Auxilium vs Competition

Auxilium vs. Perrigo Co
Auxilium vs. Herbalife Ltd
Auxilium vs. Prestige Brands Holdings Inc
Auxilium vs. USANA Health Sciences Inc
Auxilium vs. Lifevantage Corporation
Auxilium vs. Natural Alternatives International Inc
Auxilium vs. Biozone Pharmaceuticals Inc
Auxilium vs. Amexdrug Corp
Auxilium vs. Cyanotech Corp

Auxilium May 20 2013 Opportunity Range

Downside Deviation4.42
Information Ratio(0.20)
Maximum Drawdown14.22
Value At Risk(3.75)
Potential Upside3.34

 
Analytics
Risk Adjusted Returns Landscape
Live Efficient Frontier
Market Correlation Analysis
Watchlist Analysis
Financial Content
Portfolio Estimation and Projections
Portfolio Theme Builder
 
 
Research Modules
Equities Backtesting Analysis
Instant Retirement Optimizer
Cross-portfolio RSS and Mobile Access
Company, fund, and ETF Directory
Financial Advisor Directory
Insider and Manager Directory
Wealth Management
 Gadgets, Widgets, and Apps          
  
 
Services And Technology
Frequently Asked Questions
Quick Product Tour
Product Technology Overview
Solution Methodology
Plans and Pricing
 
Free Investor Tools
World Market Correlations
Instant Equity Comparator
Watchlist Analysis
Position Suggestions
Equity Alpha Analysis
 
About Us
About Macroaxis
Contact Us
Product Terms Of Use
Service Privacy Policy
Advertising Opportunities
Content

Thanks for checking out Macroaxis

Tell us what you like and what you don't like. We promise we'll not only listen but write you back

Contact Us
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide. Please fill out our quick survey to help us provide your with a better service and user experience

Fill Out Quick Survey
Most of the functionality on our site is free to use. However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory

Go Premium